LABU vs. PRXV

Last updated Jun 3, 2026

LABU (Direxion Daily S&P Biotech Bull 3x Shares) and PRXV (Praxis Impact Large Cap Value ETF) are both exchange-traded funds - LABU is a Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (300%), while PRXV is a Large Cap Value Equities fund actively managed by Praxis. LABU is passively managed, while PRXV is actively managed. At a 0.30 correlation, their price movements are largely independent. LABU charges 1.12%/yr vs 0.36%/yr for PRXV.

Performance

LABU vs. PRXV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Praxis Impact Large Cap Value ETF (PRXV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

LABU

• 1D: -12.94%
• 1M: -8.90%
• YTD: -0.77%
• 6M: 7.41%
• 1Y: 193.25%
• 3Y*: 6.21%
• 5Y*: -33.29%
• 10Y*: -13.92%

PRXV

• 1D: 0.86%
• 1M: 3.47%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LABU vs. PRXV - Yearly Performance Comparison

	2026 (YTD)
LABU Direxion Daily S&P Biotech Bull 3x Shares	-23.41%
PRXV Praxis Impact Large Cap Value ETF	4.54%

Correlation

The correlation between LABU and PRXV is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026	0.30

Return for Risk

LABU vs. PRXV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABU

LABU Risk / Return Rank: 76
LABU Sharpe Ratio Rank: 78
LABU Sortino Ratio Rank: 62
LABU Omega Ratio Rank: 55
LABU Calmar Ratio Rank: 94
LABU Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABU vs. PRXV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Praxis Impact Large Cap Value ETF (PRXV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LABU	PRXV	Difference
Sharpe ratio Return per unit of total volatility	2.57	—	—
Sortino ratio Return per unit of downside risk	2.91	—	—
Omega ratio Gain probability vs. loss probability	1.34	—	—
Calmar ratio Return relative to maximum drawdown	7.09	—	—
Martin ratio Return relative to average drawdown	20.95	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	LABU	PRXV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.57	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.35	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.15	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.24	4.69	-4.93

Drawdowns

LABU vs. PRXV - Drawdown Comparison

The maximum LABU drawdown since its inception was -99.18%, which is greater than PRXV's maximum drawdown of -1.18%. Use the drawdown chart below to compare losses from any high point for LABU and PRXV.

Drawdown Indicators

	LABU	PRXV	Difference
Max Drawdown Largest peak-to-trough decline	-99.18%	-1.18%	-98.00%
Max Drawdown (1Y) Largest decline over 1 year	-30.70%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-78.30%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-97.59%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-98.96%	—	—
Current Drawdown Current decline from peak	-96.50%	0.00%	-96.50%
Average Drawdown Average peak-to-trough decline	-81.67%	-0.33%	-81.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.40%	—	—

Volatility

Volatility by Period

	LABU	PRXV	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.40%	—	—
Volatility (6M) Calculated over the trailing 6-month period	60.11%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	76.20%	9.81%	+66.39%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.56%	9.81%	+85.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.43%	9.81%	+85.62%

LABU vs. PRXV - Expense Ratio Comparison

LABU has a 1.12% expense ratio, which is higher than PRXV's 0.36% expense ratio.

Dividends

LABU vs. PRXV - Dividend Comparison

LABU's dividend yield for the trailing twelve months is around 0.78%, while PRXV has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
LABU Direxion Daily S&P Biotech Bull 3x Shares	0.78%	0.84%	0.35%	0.35%	0.00%	0.00%	0.00%	0.28%	0.64%	0.17%
PRXV Praxis Impact Large Cap Value ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both LABU and PRXV in my portfolio?

LABU and PRXV have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, LABU or PRXV?

On fees, PRXV is cheaper at 0.36% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, LABU or PRXV?

PRXV is cheaper with a 0.36% expense ratio, compared with 1.12% for LABU.

Which ETF pays a higher dividend yield, LABU or PRXV?

LABU has the higher dividend yield at 0.78%, compared with 0.00% for PRXV.

What is the main difference between LABU and PRXV?

LABU is categorized as Leveraged Equities, while PRXV is Large Cap Value Equities. They also come from different issuers: Direxion and Praxis. Their fees differ too: 1.12% for LABU and 0.36% for PRXV.